Ms. Dinah Essien, WHNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 11 Lincoln Blvd, Clark, NJ 07066 Phone: 732-388-1508 Fax: 732-388-9040 |
Kelly Barrameda, APN, RN, AGPCNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Walnut Ave # 610, Clark, NJ 07066 Phone: 908-583-5630 |
Mrs. Michelle Destouche, APN Registered Nurse Medicare: Medicare Enrolled Practice Location: 241 Westfield Ave, Clark, NJ 07066 Phone: 866-389-2727 |
Loren Evelyn Hernandez, RN Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 142 Broadway, Clark, NJ 07066 Phone: 908-367-1811 |
Yerelyn Gutierrez, FNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 241 Westfield Ave, Clark, NJ 07066 Phone: 731-381-7100 |
Irina Costa, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 31 Union County Pkwy, Clark, NJ 07066 Phone: 908-531-5543 |
News Archive
EMC Corporation, the world leader in information infrastructure solutions, today announced that Aspirus, a non-profit system of hospitals, clinics and other healthcare facilities with more than 4,200 employees and more than 400 licensed inpatient beds in its system, is helping its practitioners streamline workflows while reducing IT administrative costs leveraging EMC solutions and services for data center consolidation and virtualization.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for ZETIA (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestine.
On the occasion of the World Cancer Day, the European Commission's Joint Research Centre launched the European Cancer Information System (ECIS), which makes it possible to explore geographical patterns and temporal trends of cancer incidence, mortality, and survival from data submitted by some 150 European population-based cancer registries.
AstraZeneca and Targacept, Inc. havey announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.
Insomnia is associated with increased risk of heart attack and stroke, according to research published today in the European Journal of Preventive Cardiology.
› Verified 2 days ago